PYPD logo

PYPD PolyPid Ltd.

NASDAQ Global Market · Biotechnology · Healthcare

$6.12
-0.43 (-6.56%)

PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III …

Market Cap: $129.29Mwww.polypid.com

Price

No data yet.

Social Signal Score

52
5d
—
30d
51
5 mentions
—
60d
53
10 mentions
—
90d
53
11 mentions
—
news: 11

Analyst Ratings

9 analysts
Buyconsensus
Strong Buy 0Buy 8Hold 1Sell 0Strong Sell 0
Avg price target$11.67+90.7%
Low $10Median $12High $13
Current Consensus

Revenue

$0.00
$0.00
Sep 2017Sep 2026

Analyst Estimates

FY2025
$-2.09
$-2.14–$-2.04
3 analysts
FY2026
$-1.09
$-1.67–$-0.04
3 analysts
FY2027
$-0.86
$-1.88–$0.14
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Dikla Czaczkes Akselbrad
Sector
Healthcare
Industry
Biotechnology
Employees
72
Beta
1.43
Country
IL
Piotroski score
2 / 9 (Weak)
Altman Z-score
-10.98
www.polypid.com